Alterations of the gene expression profile in renal cell carcinoma after treatment with the histone deacetylase-inhibitor valproic acid and interferon-alpha.

Juengel, E, Bhasin, M, Libermann, T, Barth, Susanne, Michaelis, Martin, Cinatl, Jindrich, Jones, J, Hudak, L, Jonas, Dietger, Blaheta, Roman A. and others. (2011) Alterations of the gene expression profile in renal cell carcinoma after treatment with the histone deacetylase-inhibitor valproic acid and interferon-alpha. World Journal of Urology, 29 (6). pp. 779-86. ISSN 1433-8726. (doi:10.1007/s00345-010-0582-y) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:34067)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided.
Official URL: http://dx.doi.org/10.1007/s00345-010-0582-y

Abstract

This data provides insight into the molecular mechanism of action of the combined treatment of VPA and IFN-alpha in RCC. Implications are that the combined application of VPA and IFN-alpha may represent a more efficient alternative to existing therapy options for RCC.

Item Type:	Article
DOI/Identification number:	10.1007/s00345-010-0582-y
Subjects:	R Medicine > RM Therapeutics. Pharmacology
Divisions:	Divisions > Division of Natural Sciences > Biosciences
Depositing User:	Martin Michaelis
Date Deposited:	05 Jun 2013 17:39 UTC
Last Modified:	16 Nov 2021 10:11 UTC
Resource URI:	https://kar.kent.ac.uk/id/eprint/34067 (The current URI for this page, for reference purposes)

University of Kent Author Information

Michaelis, Martin.

Creator's ORCID:	https://orcid.org/0000-0002-5710-5888
CReDIT Contributor Roles:

Depositors only (login required):

Altmetric

Download Statistics

Total unique views for this document in KAR since July 2020. For more details click on the image.